Fanconi Anemia, Complementation Group N

Explore clinical trials studying Fanconi Anemia, Complementation Group N. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Fanconi Anemia, Complementation Group N trial results

Recruiting

NCT04038502

Conditions: BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations: VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States

Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States

Washington DC VA Medical Center, Washington, DC Washington D.C., District of Columbia, United States

Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States

View all 18 locations

Recruiting

NCT06458712

Conditions: Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Anophthalmia with pulmonary hypoplasia, Fanconi Anemia, Complementation Group D1, +1 more
Locations: Yale Cancer Center - Yale New Haven Hospital New Haven, Connecticut, United States

Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, United States

The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

Institut Bergonie Bordeaux, France

View all 21 locations